💊 Cyendiv 100 mg Capsule | Nintedanib | Lung Disease & Cancer Treatment | Export Supplier
Cyendiv 100 mg Capsule contains Nintedanib, a targeted therapy used in the treatment of idiopathic pulmonary fibrosis (IPF) and non-small cell lung cancer (NSCLC). It works by inhibiting multiple tyrosine kinases, helping to slow disease progression and abnormal cell growth.
🔹 Product Category
Specialty Medicine (Targeted Therapy / Tyrosine Kinase Inhibitor)
🔹 Composition
Nintedanib 100 mg
🔹 Indications
✔ Idiopathic Pulmonary Fibrosis (IPF)
✔ Non-Small Cell Lung Cancer (NSCLC)
🔹 Key Benefits
✔ Slows progression of lung fibrosis
✔ Targeted therapy (multi-kinase inhibitor)
✔ Oral capsule (patient-friendly)
✔ Used in advanced treatment protocols
🔹 Dosage & Administration
✔ Oral capsule as prescribed
✔ Usually taken twice daily
✔ Dosage based on patient condition
✔ Under strict medical supervision
🔹 Packaging
✔ Blister / Bottle Packaging
✔ Bulk Export Available
✔ Private Labeling Supported
🔹 Certifications
✔ WHO-GMP Certified
✔ COA & COPP Available
🌍 Target Export Markets & Cities
🇺🇸 USA: New York, Los Angeles, Houston
🇬🇧 UK: London, Manchester
🇦🇪 UAE: Dubai, Abu Dhabi
🇸🇬 Singapore: Singapore
🇮🇳 India: Mumbai, Delhi, Bangalore
🇵🇭 Philippines: Manila
🇻🇳 Vietnam: Ho Chi Minh City, Hanoi
🇿🇦 South Africa: Johannesburg, Cape Town
🇳🇬 Nigeria: Lagos, Abuja
🇰🇪 Kenya: Nairobi
🇧🇷 Brazil: São Paulo
🇲🇽 Mexico: Mexico City
🇵🇪 Peru: Lima
📍 Location: Nagpur, Maharashtra, India
📦 Product Catalogue Available
✔ Oncology Medicines
✔ HIV & Antiviral Medicines
✔ Specialty Pharmaceutical Products
📞 Instant Support – Call / WhatsApp Now
📲 +91 8007161282
📲 +91 9970011496
💬 Quick replies for urgent orders & inquiries!
🌐 Visit Our Official Websites
🔹 www.pacificmedicines.com
🔹 www.indocares.com
🔹 www.indiamedexport.com
📧 Business Enquiries & Bulk Orders
✉️ sales@pacificmedicines.com
#Nintedanib
#LungDisease
#PulmonaryFibrosis
#NSCLC
#TargetedTherapy
#OncologyMedicines
#PharmaExport
#GlobalPharma
#B2BHealthcare
#IndiaPharma
